Indivior Inc. is a pharmaceutical company that develops treatments for substance use disorders. It lobbies Congress on pharmacy-related rules and Medicare and Medicaid policies, and has pushed on funding and rules around overdose-reversal products like naloxone. Filings show four reports totaling $200,000 and they used Crossroads Strategies, LLC.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
MATHEW LAPINSKI
The latest disclosures for this client.
CROSSROADS STRATEGIES, LLC
1TYCROSSROADS STRATEGIES, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CROSSROADS STRATEGIES, LLC
BRITTANY JOHNSON HERNANDEZ
CROSSROADS STRATEGIES, LLC
JASON BENJAMIN VAN PELT
CROSSROADS STRATEGIES, LLC
ms CHERYL LYNN JAEGER
CROSSROADS STRATEGIES, LLC
ms IVELISSE ALEXANDRA PORROA-GARCIA
CROSSROADS STRATEGIES, LLC
CROSSROADS STRATEGIES, LLC
Q3CROSSROADS STRATEGIES, LLC
Q2CROSSROADS STRATEGIES, LLC
Q1